Literature DB >> 2682134

Effects of free fatty acids and ketone bodies on in vivo non-insulin-mediated glucose utilization and production in humans.

A D Baron1, G Brechtel, S V Edelman.   

Abstract

The current study was undertaken to examine the effect of an acute elevation of serum levels of free fatty acids (FFA) and ketone bodies (KB) on non-insulin-mediated glucose uptake (NIMGU) in humans. The study group consisted of 11 healthy men, mean age (+/- SD) 30 (+/- 7) years and mean weight (+/- SD) 72 (+/- 7) kg. To examine the effects of FFA levels on NIMGU and insulin-mediated glucose uptake (IMGU), glucose uptake was measured isotopically (3H-3-glucose) in six subjects on four separate days during saline infusion or lipid + heparin infusion with concomitant infusions of somatostatin (SHIF, 0.16 micrograms/kg/min) with or without insulin infusion (40 mU/m2/min) while the serum glucose level was clamped at approximately 11 mmol/L. To examine the effect of KB on NIMGU, saline or sodium acetoacetate (20 mumol/kg/min) was infused in five subjects on separate days during SRIF-induced insulinopenia while the serum glucose level was clamped sequentially at euglycemia and at approximately 11 mmol/L. During insulinopenia basal FFA levels rose twofold during saline infusion and sixfold during infusion of lipid + heparin. Rates of NIMGU were 2.49 +/- 0.27 v 2.41 +/- 0.14 mg/kg/min during saline and lipid infusion, respectively (P = NS). Rates of IMGU were decreased by 55% during lipid + heparin infusion. During insulinopenia basal beta-hydroxybutyrate (BOB) levels rose twofold during saline and approximately 11-fold during sodium acetoacetate infusion. Rates of NIMGU were unchanged by the sodium acetoacetate infusion at euglycemia and hyperglycemia.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2682134     DOI: 10.1016/0026-0495(89)90040-1

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

1.  Fatty acids increase glucose uptake and metabolism in C2C12 myoblasts stably transfected with human lipoprotein lipase.

Authors:  Warren H Capell; Isabel R Schlaepfer; Pamela Wolfe; Peter A Watson; Daniel H Bessesen; Michael J Pagliassotti; Robert H Eckel
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-07-13       Impact factor: 4.310

2.  Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.

Authors:  C Fanelli; S Calderone; L Epifano; A De Vincenzo; F Modarelli; S Pampanelli; G Perriello; P De Feo; P Brunetti; J E Gerich
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

3.  Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  C Saloranta; A Franssila-Kallunki; A Ekstrand; M R Taskinen; L Groop
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

4.  The effect of an antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patients.

Authors:  C Saloranta; L Groop; A Ekstrand; A Franssila-Kallunki; M R Taskinen
Journal:  Acta Diabetol       Date:  1994-04       Impact factor: 4.280

Review 5.  Potential Synergies of β-Hydroxybutyrate and Butyrate on the Modulation of Metabolism, Inflammation, Cognition, and General Health.

Authors:  Franco Cavaleri; Emran Bashar
Journal:  J Nutr Metab       Date:  2018-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.